Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd
Oncology drugs
Fierce Biotech
A 5-month sprint: Inside Pfizer's $10B deal with Innovent
Leveraging interest from other parties, Innovent at one point threatened to walk away if Pfizer didn’t agree to its co-development terms.
Angus Liu
Jun 21, 2026 10:41pm
Verastem mulls options on approved asset in pancreatic cancer
Jun 17, 2026 3:00pm
Daiichi Sankyo targets global top 5 oncology rank by 2035
May 11, 2026 10:22am
Pfizer's COVID franchise keeps guidance level after strong Q1
May 5, 2026 11:17am
Gates-backed TerraPower sketches out $450M radioisotope facility
Mar 18, 2026 10:40am
Lilly's Retevmo succeeds as adjuvant treatment in NSCLC
Feb 17, 2026 11:02am
